Related Experiment Videos
Clinical experience with BioMedicus centrifugal ventricular support in 172 patients
G P Noon1, J W Ball, H T Papaconstantinou
1Department of Surgery, Baylor College of Medicine, Methodist Hospital, Houston, Texas 77030, USA.
Artificial Organs
|July 1, 1995
Summary
BioMedicus centrifugal ventricular support offers a rapid, easy, and cost-effective option for patients needing temporary cardiac assistance. This system demonstrates potential benefits for a significant number of individuals requiring ventricular support.
Area of Science:
- Cardiovascular Surgery
- Medical Devices
- Critical Care Medicine
Background:
- Temporary mechanical circulatory support is crucial for managing severe cardiac conditions.
- The BioMedicus centrifugal ventricular assist device is a system used in critical care settings.
Purpose of the Study:
- To evaluate the efficacy and outcomes of BioMedicus centrifugal ventricular support in a patient cohort.
- To identify complications and survival rates associated with this ventricular assist device.
Main Methods:
- A retrospective analysis of 172 patients who received BioMedicus centrifugal ventricular support at The Methodist Hospital.
- Data collected included patient demographics, reasons for support, device configuration, weaning success, discharge rates, complications, and causes of death.
Main Results:
- Out of 172 patients, 48.8% were weaned successfully, and 20.0% were discharged. Ventricular failure was the leading cause of death (55.1%).
- Common complications included coagulopathy, renal and respiratory insufficiency, neurological deficits, sepsis, and arrhythmias.
- Device-related complications were low (1.2%), and the system is noted for its rapid implementation and cost-effectiveness.
Conclusions:
- BioMedicus centrifugal ventricular support is a feasible and potentially beneficial temporary mechanical circulatory support option.
- The system demonstrates a low rate of device-related complications and offers a cost-effective alternative.
- Further research may explore patient selection criteria to optimize outcomes for temporary centrifugal ventricular support.